| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | 16.65M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, NERV returned +98.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +20.4% |
| 1 year | +98.8% |
| 5 years | -67.1% |
| 10 years | -95.0% |
| All-time high | $112.92 (Sep 2016) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in NERV would be worth today ›No. Minerva Neurosciences, Inc. has not paid a dividend in the past 12 months.
Minerva Neurosciences, Inc. stock trades on NASDAQ under the ticker symbol NERV.
Minerva Neurosciences, Inc. is part of the Healthcare sector.
Minerva Neurosciences, Inc. has a market cap of 231.10M USD, based on the latest quote.
